Quantification of Alzheimer Amyloid β Peptides Ending at Residues 40 and 42 by Novel ELISA Systems

Molecular Medicine

Volumn 6, Issue 4, 2000, Pages 291-302

  Jensen, Malene ^a   Hartmann, Tobias ^b   Engvall, Benita ^a   Wang, Rong ^c   Uljon, Sacha N ^c   Sennvik, Kristina ^a   Näslund, Jan ^a   Muehlhauser, Frank ^b   Nordstedt, Christer ^a   Beyreuther, Konrad ^b   Lannfelt, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Enzymelinked Immunosorbent Assay (ELISA); Epitope Mapping Experiments; Matrix assisted Laser Desorption ionization Time of flight Mass Spectrometry (MALDI TOF MS); Peptide Ends; Synthetic A 1 40

Indexed keywords

ALBUMINOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CEREBROSPINAL FLUID; CHEMISTRY; CULTURE MEDIUM; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNOLOGY; LABORATORY DIAGNOSIS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SYNTHESIS; TEMPERATURE; ULTRASTRUCTURE;

ALBUMINS; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CEREBROSPINAL FLUID; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; MASS SPECTROMETRY; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SPECIMEN HANDLING; TEMPERATURE;

MLCS; MLOWN;

EID: 0034168240     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401938     Document Type: Article

References (35)

1. J. Kang H.-G. Lemaire A. Unterbeck et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor Nature 1987 325 733 736 10.1038/325733a0 1:CAS:528:DyaL2sXktVWkt7s%3D 2881207
2. C. Haass M.G. Schlossmacher A.Y. Hung et al. Amyloid β-peptide is produced by cultured cells during normal metabolism Nature 1992 359 322 325 10.1038/359322a0 1:CAS:528:DyaK38XmtV2msro%3D 1383826
3. P. Seubert C. Vigo-Pelfrey F. Esch et al. Isolation and quantification of soluble Alzheimer’s β-peptide from biological fluids Nature 1992 359 325 327 10.1038/359325a0 1:CAS:528:DyaK38XmtFSisrc%3D 1406936
4. −APP 717) mutants Science 1994 264 1336 1340 10.1126/science.8191290 1:CAS:528:DyaK2cXltlWntbY%3D 8191290
5. D. Scheuner C. Eckman M. Jensen et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease Nat. Med. 1996 2 864 870 10.1038/nm0896-864 1:CAS:528:DyaK28XkslGiu7g%3D 8705854
6. M. Jensen J. Schroder M. Blomberg et al. Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer’s disease and declines with disease progression Ann. Neurol. 1999 45 504 511 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9 1:STN:280:DyaK1M3is1CmtQ%3D%3D 10211475
7. W.A. van Gool M.A. Kuiper G.J.M. Walstra E.C. Wolters P.A. Bolhuis Concentrations of amyloid β protein in cerebrospinal fluid of patients with Alzheimer’s disease Ann. Neurol. 1995 37 277 279 10.1002/ana.410370221 7847870
8. L. Lannfelt H. Basun C. Vigo-Pelfrey et al. Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation Neurosci. Lett. 1995 199 203 206 10.1016/0304-3940(95)12059-D 1:CAS:528:DyaK2MXptVemsLg%3D 8577398
9. R.M. Nitsch W.G. Rebeck M. Deng et al. Cerebrospinal fluid levels of amyloid β-protein in Alzheimer’s disease: inverse severity of dementia and effect of ApoE genotype Ann. Neurol. 1995 37 512 518 10.1002/ana.410370414 1:STN:280:DyaK2M3jtlOgug%3D%3D 7717688
10. R. Motter C. Vigo-Pelfrey D. Kholodenko et al. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer’s disease Ann. Neurol. 1995 38 643 648 10.1002/ana.410380413 1:STN:280:DyaK28%2FgtFahsw%3D%3D 7574461
11. A. Tamaoka N. Sawamura T. Fukushima et al. Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer’s disease J. Neurol. Sci. 1997 148 41 45 10.1016/S0022-510X(96)00314-0 1:CAS:528:DyaK2sXhtlygtLo%3D 9125389
12. D. Galasko L. Chang R. Motter et al. High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype Arch. Neurol. 1998 55 937 945 10.1001/archneur.55.7.937 1:STN:280:DyaK1czktFCmsw%3D%3D 9678311
13. M. Kanai E. Matsubara K. Isoe et al. Longitudinal study of cerebrospinal fluid levels of tau, Aβ40, and Aβ42(43) in Alzheimer’s disease: a study in Japan Ann. Neurol. 1998 44 17 26 10.1002/ana.410440108 1:CAS:528:DyaK1cXkvVWmurw%3D 9667589
14. N. Andreasen C. Hesse P. Davidsson et al. Cerebrospinal fluid β-amyloid(1–42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch. Neurol. 1999 56 673 680 10.1001/archneur.56.6.673 1:STN:280:DyaK1M3psF2kuw%3D%3D 10369305
15. F. Hulstaert K. Blennow A. Ivanoiu et al. Improved discrimination of AD patients using β-amyloid(1–42) and tau levels in CSF Neurology 1999 52 1555 1562 10.1212/WNL.52.8.1555 1:STN:280:DyaK1M3mtVGhsw%3D%3D 10331678
16. P.C. Southwick S.K. Yamagata C.L. Echols et al. Assessment of amyloid β protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer’s disease J. Neurochem. 1996 66 259 266 10.1046/j.1471-4159.1996.66010259.x 1:CAS:528:DyaK2MXhtVSns7nM 8522962
17. T. Nakamura M. Shoji Y. Harigaya et al. Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer’s disease Ann. Neurol. 1994 36 903 911 10.1002/ana.410360616 1:CAS:528:DyaK2MXjsVehsrk%3D 7998778
18. M. Tabaton M. Grazia Nunzi R. Xue M. Usiak L. Autilio-Gambetti P. Gambetti Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid Biochem. Biophys. Res. Com. 1994 200 1598 1603 10.1006/bbrc.1994.1634 1:CAS:528:DyaK2cXktVKmsb0%3D 8185615
19. N. Ida T. Hartmann J. Pantel et al. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay J. Biol. Chem. 1996 271 22908 22914 10.1074/jbc.271.37.22908 1:CAS:528:DyaK28Xlslagu7g%3D 8798471
20. A. Tamaoka T. Fukushima N. Sawamura et al. Amyloid β protein in plasma from patients with sporadic Alzheimer’s disease J. Neurol. Sci. 1996 151 65 68 10.1016/0022-510X(96)00143-8
21. R. Frank Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support Tetrahedron 1992 48 9217 9232 10.1016/S0040-4020(01)85612-X 1:CAS:528:DyaK3sXhtVansbw%3D
22. R. Wang D. Sweeney S.E. Gandy S.S. Sisodia The profile of soluble amyloid β protein in cultured cell media J. Biol. Chem. 1996 271 31894 31902 10.1074/jbc.271.50.31894 1:CAS:528:DyaK2sXitFGrtQ%3D%3D 8943233
23. M. Pitschke R. Prior M. Haupt D. Riesner Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer’s patients by fluorescence correlation spectroscopy Nat. Med. 1998 4 832 834 10.1038/nm0798-832 1:CAS:528:DyaK1cXktlKns7Y%3D 9662376
24. A.L. Biere B. Ostazewski E. Stimson B.T. Hyman J.E. Maggio D.J. Selkoe Amyloid β peptide is transported in lipoproteins and albumin in human plasma J. Biol. Chem. 1996 271 32916 32922 10.1074/jbc.271.51.32916 1:CAS:528:DyaK2sXnt1Sq 8955133
25. B. Bohrmann L. Tjernberg P. Kuner et al. Endogenous proteins controlling amyloid β-peptide polymerization J. Biol. Chem. 1999 274 15990 15995 10.1074/jbc.274.23.15990 1:CAS:528:DyaK1MXjs1OgurY%3D 10347147
26. A. Golabek M.A. Marques M. Lalowski T. Wisniewski Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid Neurosci. Lett. 1995 191 79 82 10.1016/0304-3940(95)11565-7 1:CAS:528:DyaK2MXlvFKksbc%3D 7659297
27. E. Matsubara C. Soto S. Governale B. Frangione J. Ghiso Apolipoprotein J and Alzheimer’s amyloid β solubility Biochem. J. 1996 316 671 679 10.1042/bj3160671 1:CAS:528:DyaK28XjvVahtbo%3D 8687416 1217400
28. A.R. Koudinov N.V. Koudinova A. Kumar R.C. Beavis J. Ghiso Biochemical characterisation of Alzheimer’s soluble amyloid β protein in human cerebrospinal fluid: association with high density lipoproteins Biochem. Biophys. Res. Com. 1996 223 592 597 10.1006/bbrc.1996.0940 1:CAS:528:DyaK28XjvFCrtb0%3D 8687441
29. K. Yanasigawa A. Odaka N. Suzuki Y. Ihara GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer’s disease Nat. Med. 1995 1 1062 1066 10.1038/nm1095-1062
30. J. McLaurin T. Franklin P.E. Fraser A. Chakrabartty Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides J. Biol. Chem. 1998 273 4506 4515 10.1074/jbc.273.8.4506 1:CAS:528:DyaK1cXhtlSrurw%3D 9468505
31. A.L. Schwarzman L. Gregori M.P. Vitek et al. Transthyretin sequesters amyloid β protein and prevents amyloid formation Proc. Natl. Acad. Sci. USA 1994 91 8368 8372 10.1073/pnas.91.18.8368 1:CAS:528:DyaK2cXlslKktLk%3D 8078889
32. K.R. Brunden N.J. Richter-Cook N. Chaturvedi R.C. Frederickson pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans J. Neurochem. 1993 61 2147 2154 10.1111/j.1471-4159.1993.tb07453.x 1:CAS:528:DyaK2cXpvFOhug%3D%3D 8245966
33. Y.-M. Kuo M.R. Emmerling H.C. Lampert et al. High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer’s disease Biochem. Biophys. Res. Com. 1999 257 787 791 10.1006/bbrc.1999.0552 1:CAS:528:DyaK1MXisVahsrw%3D 10208861
34. T. Wisniewski E. Castano J. Ghiso B. Frangione Cerebrospinal fluid inhibits Alzheimer β-amyloid fibril formation in vitro Ann. Neurol. 1993 34 631 633 10.1002/ana.410340422 1:CAS:528:DyaK2cXitFCgsbY%3D 8215255
35. Y.-M. Kuo M.R. Emmerling C. Vigo-Pelfrey et al. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains J. Biol. Chem. 1996 271 4077 4081 10.1074/jbc.271.8.4077 1:CAS:528:DyaK28XhtlSmsL8%3D 8626743